Navigation Links
Food and Drug Administration (FDA) Joins Pharma IQ's Viral Safety 2011 Conference
Date:8/22/2011

LONDON, August 22, 2011 /PRNewswire/ --

Santosh Nanda, Microbiologist/ Primary Reviewer, CBER, FDA and Rebecca Sheets, Vaccine Scientific and Regulatory Specialist, NIH/NIAID have announced their official participation at the Viral Safety 2011 conference due to take place from the 17th October to 19th October 2011 in NH München Dornach, Munich, Germany.

This year's conference has expanded its focus from solely viral safety to encompass mycoplasma, TSE and bacteria. The event will have a strong focus on prevention and regulatory compliance as well as offering a nature of discussion based and interactive sessions.

Systematically Characterising Adventitious Agent Tests for Biologics

At the conference, Rebecca Sheets will be discussing the policy perspective on adapting new testing methodologies, she will assess the breadth and sensitivity of routine adventitious agent tests and will cover the harmonisation of test methods (both existing and emerging).

On the other hand, Santosh Nanda will be sharing a regulatory perspective on how to evaluate the Safety of New Flu Vaccine Development Methods, he will assess the risks of the cell-based development process and will also Investigate the challenges and benefits of utilising cell based vaccine development and developing regulatory guidance to govern the process.

The Viral Safety 2011 conference aims at creating effective strategies to mitigate risk and enable prompt remediation of viral, prion and mycoplasma contamination - it will provide an interactive forum for learning best practices, keeping abreast of new developments and forging lasting business relationships.

20 biotech and biopharma experts are getting together this October to share updates and insights on how to escape contamination and get your products to market safely, speedily and successfully.

To view the conference programme (including full speaker and session information) visit

http://www.adventitiousagentsevent.com/redForms.aspx?id=553186&pdf_form=1


Find event details and registration information on http://www.adventitiousagentsevent.com/news2 or email enquire@iqpc.co.uk

Media contact: Veronica Araujo, +44(0)20-7368-9748, veronica.araujo@iqpc.co.uk or visit  http://www.adventitiousagentsevent.com/news2

 

Press are invited to attend this important industry forum, if you would like to a complimentary press pass please email Veronica Araujo (veronica.araujo@iqpc.co.uk)


'/>"/>
SOURCE Pharma IQ
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Biological Psychiatry Publishes Study Showing VYVANSE Demonstrated Significant Efficacy for Treatment of ADHD for up to 12 Hours After Administration
2. Supplemental New Drug Application for PREZISTA(TM) Submitted to U.S. Food and Drug Administration
3. Northwestern Offers Clinical Research and Regulatory Administration Graduate Certificate Program
4. U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for the Acute Treatment of Manic and Mixed Episodes Associated With Bipolar I Disorder in Pediatric Patients (10 to 17 Years of Age)
5. Ortho Biotech Statement on U.S. Food and Drug Administration Oncologic Drugs Advisory Committee Vote
6. U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older
7. Treprostinil Data Presented at American Thoracic Society Conference Demonstrates Significant Clinical Progress in All Four Routes of Administration
8. Lilly Submits Cymbalta(R) Supplemental New Drug Application for Chronic Pain to U.S. Food and Drug Administration
9. Genmab A/S - Company Announcement Ofatumumab in Subcutaneous Study in Rheumatoid Arthritis Summary: Subcutaneous Administration of Ofatumumab Investigated in Phase I/II Study
10. Vermillion Files 510(k) Application With U.S. Food & Drug Administration for OVA1 Ovarian Tumor Triage Test
11. New Drug Application for Inhaled Treprostinil Submitted to the U.S. Food and Drug Administration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/18/2017)... , May 17, 2017  Bayer announced today ... portfolio will be presented at the 53 rd ... (ASCO), taking place June 2-6 in Chicago ... at ASCO span prostate, colorectal, liver and thyroid cancers, ... from the Phase II CHRONOS-1 trial of copanlisib in ...
(Date:5/10/2017)... Hologic, Inc. (Nasdaq: HOLX ) announced today ... ended April 1, 2017 .   GAAP diluted earnings ... the prior year period as the sale of the ... non-GAAP diluted EPS of $0.50 increased 6.4%.  Revenue of ... terms.  Excluding the effects of blood screening and the ...
(Date:5/9/2017)... Ind. , May 9, 2017 Zimmer ... leader in musculoskeletal healthcare, today announced it has earned ... Employers of 2017" list. The Company was ranked among ... of Large Employers and Healthcare Equipment and Services. ... employers based on an anonymous, independent survey of over ...
Breaking Medicine Technology:
(Date:5/27/2017)... ... May 27, 2017 , ... From May 21-23, hearing healthcare professionals gained ... was held at the Marriott Syracuse Downtown Hotel in Syracuse, New York. , ... of independent hearing healthcare providers to help them stay ahead in the industry. At ...
(Date:5/26/2017)... ... May 26, 2017 , ... Mediaplanet is proud to ... campaign in USA Today, which will educate readers on how to take care of ... a large focus is placed on melanoma. Dancing with the Stars professional, Witney Carson, ...
(Date:5/26/2017)... ... May 26, 2017 , ... Leading CEOs ... on May 30th and 31st at The Four Seasons Hotel Boston. , ... the life sciences, offering exclusive access to key decision makers who influence deal ...
(Date:5/26/2017)... ... ... Amir Qureshi, MD is the first physician in Arkansas to implant Nuvecta’s ... Nuvectra™ Algovita SCS System has been FDA approved as a treatment option for chronic ... introduce the most powerful SCS system and the only stretchable lead on the market. ...
(Date:5/26/2017)... ... May 26, 2017 , ... A new analysis of community ... healthiest seniors are located in the Midwest. With the average cost of healthcare rising ... are concerned with both the quality and affordability of where they live. An annual ...
Breaking Medicine News(10 mins):